|Session title||Collaborative biomedical innovation in Africa to eliminate infectious diseases|
|Coordinator||Linet Atieno Otieno, Senior Communications Manager, DNDi Africa|
|Hosts||Drugs for Neglected Diseases initiative (DNDi)|
|Session Format (select one)||Panel Discussion||Workshop||Plenary|
|Chairs||Chair: Dr. John Amuasi, ARNTD and Lancet Commission|
|Speaker 1 (Policy/Govt)||Dr. Khadija Yahya-Malima||Chief Research Officer and Consultant Epidemiologist, Commission on Science and Technology, Tanzania||Invited|
|Speaker 2 (Academia)||Dr. Matthew Njoroge||Senior Investigator, DMPK at Drug Discovery and Development Centre (H3D), University of CapeTown||Confirmed|
|Speaker 3 (Civil Society)||Dr. Monique Wasunna||Director, Drugs for Neglected Diseases initiative Africa Regional Office||Confirmed|
|Speaker 4 (Private sector)||Dr. Hayato Urabe||Senior Director of Investment Strategy and Management Global Health Innovative Technology (GHIT) Fund||Confirmed|
|Speaker 5 (Policy/Govt)||Dr. Janet Byaruhanga||Senior Programme Officer, Public Health
|Dr. Alfred Mubangizi||Assistant Commissioner Health Services -Vector Borne and Neglected Tropical Diseases (VB &NTD) Division at the Ministry of Health||Confirmed|
Session Virtual Link: Digital Session, Meeting ID: 922 5911 7995
|Session Abstract||Biomedical research in Africa is growing in experience and depth and is focused on producing affordable access to medicines that meet African priority health needs. This panel brings together leading actors from the continent in developing, delivering, and funding current and future research, being led by African researchers, working with affected communities, on the African continent, for Africa and beyond. Their efforts target some of the most neglected diseases on the planet, which affect large numbers of people, but which do not attract sufficient resources because the people they hit hardest are poor or otherwise vulnerable and stigmatized.
Diverse research partnerships have, in African tradition, pooled and harnessed scarce resources to impressive ends, tackling malaria, worm, bacterial and fungal diseases that kill stunt, and cause disfigurement and stigma. 2021 is a pivotal year for NTDs – the World Health Organization will lay out its global NTD roadmap, to guide multilateral and national efforts for the coming decade.
The panellists will share insights from their experience and make proposals for how to extend their success, to ensure that by 2030, in line with the Sustainable Development Goals, neglected tropical diseases will no longer be a public health problem on the continent.
Dr. Alfred Mubangizi; Role of Ministries of Health in fostering biomedical innovation
Dr. Matthew Njoroge; H3D: Leading integrated Drug Discovery in Africa
Dr. Khadija Yahya-Malima; Commission on Science and Technology, Tanzania: From drug development to Implementation
Dr. Janet Byaruhanga; AUDA-NEPAD: Innovative regulatory approaches
Dr. Monique Wasunna; DNDi Africa: Innovative Platforms to tackle NTDs in Africa.
Dr. Hayato Urabe; GHIT Fund: Funding end-to-end approaches to beat NTDs/ Funding medical innovations for neglected populations
Event Timeslots (1)
ROOM 5 MEERA